Schmid A, Pugin J, Chevrolet J-C, Marsch S, Ludwig S, Stocker R, Finnern H
HealthEcon AG, Basel, Switzerland.
Swiss Med Wkly. 2004 Feb 21;134(7-8):97-102. doi: 10.4414/smw.2004.10475.
This study aims to determine the burden of illness imposed by severe sepsis in Switzerland by evaluating the direct and indirect patient-related costs for critically ill patients with severe sepsis.
In order to estimate the direct costs a retrospective analysis was undertaken using records from 61 adult patients treated in three intensive care units (ICUs) in three different University hospitals in Switzerland, in 2001. Resource use was determined by a bottom up approach and valued using centre-specific unit costs for medication, nutrition, blood products, disposables and official tariffs for laboratory and microbiology analysis, diagnostic services, and clinical procedures. By adding centre-specific personnel and basic bed (hotel) costs total direct costs in the ICU were calculated. Indirect costs resulting from unfitness for work, early retirement, and premature death were calculated using official Swiss statistics for the years 1998-2000.
The mean total direct costs for a severely septic patient are CHF 41,790 (+/- 33,222 CHF) or CHF 3244 (+/- 757 CHF) per day. Nonsurvivors cause significantly higher costs than survivors (CHF 45,956 vs. CHF 37,759, p <0.001). The total intensive care costs in Switzerland due to severe sepsis amount to CHF 146-355 million. Indirect costs were estimated to range from CHF 347 to 844 million (predominantly due to premature death). Consequently the burden of illness of severe sepsis can be estimated to range from CHF 493 to 1199 million per year in Switzerland (1 CHF = 0.662 Euro in 2001).
Patients suffering from severe sepsis in Switzerland have a high mortality rate and spend a prolonged time in the ICU, leading to high direct and indirect costs. Particularly productivity losses due to premature death represent a considerable burden to the Swiss society.
本研究旨在通过评估重症脓毒症危重症患者的直接和间接患者相关成本,确定瑞士重症脓毒症所造成的疾病负担。
为了估计直接成本,采用回顾性分析方法,利用2001年瑞士三家不同大学医院的三个重症监护病房(ICU)中61例成年患者的记录。资源使用情况通过自下而上的方法确定,并使用各中心特定的药品、营养、血液制品、一次性用品单位成本以及实验室和微生物分析、诊断服务及临床操作的官方收费标准进行估值。通过加上各中心特定的人员和基本床位(酒店)成本,计算出ICU的总直接成本。因无法工作、提前退休和过早死亡导致的间接成本,使用瑞士1998 - 2000年的官方统计数据进行计算。
一名重症脓毒症患者的平均总直接成本为41,790瑞士法郎(±33,222瑞士法郎),即每天3244瑞士法郎(±757瑞士法郎)。非幸存者的成本显著高于幸存者(45,956瑞士法郎对37,759瑞士法郎,p<0.001)。瑞士因重症脓毒症产生的重症监护总费用达1.46 - 3.55亿瑞士法郎。间接成本估计在3.47亿至8.44亿瑞士法郎之间(主要由于过早死亡)。因此,瑞士每年重症脓毒症的疾病负担估计在4.93亿至11.99亿瑞士法郎之间(2001年1瑞士法郎 = 0.662欧元)。
瑞士的重症脓毒症患者死亡率高,在ICU停留时间长,导致高昂的直接和间接成本。特别是过早死亡造成的生产力损失给瑞士社会带来了相当大的负担。